«BioEq», a dedicated clinical research site, invites patients with Extensive Stage Small Cell Lung Cancer to participate in a phase III clinical trial of an original immune drug as a supporting treatment after first linePlatinum-based Chemotherapy.
Investigational product: an original immune drug.
All examinations and medicines are provided free of charge. Also, during all study visits, except the first one, free taxi drive is provided.
We invite men and women starting from 18 years old with:
- Confirmed Extensive Stage Small-cell Lung Cancer, who have favorable clinical results after 4 cycles of first-line platinum-based chemotherapy (cisplatin or carboplatin combined with etoposide or irinotecan).
If you are interested in this research or you have questions about participation, you can contact us during the business days from 10 am to 6 pm at 8-812-945-22-32